A new trading day began on Monday, with C4 Therapeutics Inc (NASDAQ: CCCC) stock price down -8.47% from the previous day of trading, before settling
On Monday, C4 Therapeutics Inc (NASDAQ: CCCC) was -11.44% drop from the session before settling in for the closing price of $2.71. A 52-week range
C4 Therapeutics Inc (NASDAQ: CCCC) open the trading on Thursday, with a bit cautious approach as it glided -1.89% to $2.60, before settling in for
A new trading day began on Monday, with C4 Therapeutics Inc (NASDAQ: CCCC) stock price down -3.99% from the previous day of trading, before settling
C4 Therapeutics Inc (NASDAQ: CCCC) kicked off on Tuesday, down -6.60% from the previous trading day, before settling in for the closing price of $3.18.
Witnessing the stock’s movement on the chart, on Thursday, C4 Therapeutics Inc (NASDAQ: CCCC) had a quiet start as it plunged -3.03% to $3.20, before
C4 Therapeutics Inc (NASDAQ: CCCC) on Monday, plunged -5.07% from the previous trading day, before settling in for the closing price of $3.55. Within the
C4 Therapeutics Inc (NASDAQ: CCCC) started the day on Wednesday, with a price increase of 7.35% at $3.65, before settling in for the price of
On Friday, C4 Therapeutics Inc (NASDAQ: CCCC) was -5.71% drop from the session before settling in for the closing price of $3.68. A 52-week range
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
